|
1
|
Baffa R, Letko J, McClung C, LeNoir J,
Vecchione A and Gomella LG: Molecular genetics ddof bladder cancer:
targets for diagnosis and therapy. J Exp Clin Cancer Res.
25:145–160. 2006.PubMed/NCBI
|
|
2
|
Stein JP, Lieskovsky G, Cote R, Groshen S,
Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M,
Raghavan D and Skinner DG: Radical cystectomy in the treatment of
invasive bladder cancer: long-term results in 1,054 patients. J
Clin Oncol. 19:666–675. 2001.PubMed/NCBI
|
|
3
|
Kirkali Z, Chan T, Manoharan M, Algaba F,
Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM,
Sesterhenn IA, Tachibana M and Weider J: Bladder cancer:
epidemiology, staging and grading, and diagnosis. Urology. 66(6
Suppl 1): 4–34. 2005. View Article : Google Scholar
|
|
4
|
Hass HG, Nehls O, Jobst J, Frilling A,
Vogel U and Kaiser S: Identification of osteopontin as the most
consistently over-expressed gene in intrahepatic
cholangiocarcinoma: detection by oligonucleotide microarray and
real-time PCR analysis. World J Gastroenterol. 14:2501–2510. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rangaswami H, Bulbule A and Kundu GC:
Osteopontin: role in cell signaling and cancer progression. Trends
Cell Biol. 16:79–87. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castellano G, Malaponte G, Mazzarino MC,
Figini M, Marchese F, Gangemi P, Travali S, Stivala F, Canevari S
and Libra M: Activation of the osteopontin/matrix
metalloproteinase-9 pathway correlates with prostate cancer
progression. Clin Cancer Res. 14:7470–7480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Das R, Mahabeleshwar GH and Kundu GC:
Osteopontin induces AP-1-mediated secretion of urokinase-type
plasminogen activator through c-Src-dependent epidermal growth
factor receptor transactivation in breast cancer cells. J Biol
Chem. 279:11051–11064. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun BS, You J, Li Y, Zhang ZF and Wang CL:
Osteopontin knockdown suppresses non-small cell lung cancer cell
invasion and metastasis. Chin Med J (Engl). 126:1683–1688.
2013.
|
|
9
|
Yang L, Zhao W, Zuo WS, Wei L, Song XR,
Wang XW, Zheng G and Zheng MZ: Silencing of osteopontin promotes
the radiosensitivity of breast cancer cells by reducing the
expression of hypoxia inducible factor 1 and vascular endothelial
growth factor. Chin Med J (Engl). 125:293–299. 2012.
|
|
10
|
Tuck AB, Chambers AF and Allan AL:
Osteopontin overexpression in breast cancer: knowledge gained and
possible implications for clinical management. J Cell Biochem.
102:859–868. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boldrini L, Donati V, Dell’Omodarme M,
Prati MC, Faviana P, Camacci T, Lucchi M, Mussi A, Santoro M,
Basolo F and Fontanini G: Prognostic significance of osteopontin
expression in early-stage non-small-cell lung cancer. Br J Cancer.
93:453–457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan HW, Ou YH, Peng SY, Liu SH, Lai PL,
Lee PH, Sheu JC, Chen CL and Hsu HC: Overexpression of osteopontin
is associated with intrahepatic metastasis, early recurrence, and
poorer prognosis of surgically resected hepatocellular carcinoma.
Cancer. 98:119–127. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schorge JO, Drake RD, Lee H, Skates SJ,
Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS and Mok SC:
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian
cancer. Clin Cancer Res. 10:3474–3478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mack PC, Redman MW, Chansky K, Williamson
SK, Farneth NC, Lara PN Jr, Franklin WA, Le QT, Crowley JJ and
Gandara DR; SWOG. Lower osteopontin plasma levels are associated
with superior outcomes in advanced non-small-cell lung cancer
patients receiving platinum-based chemotherapy: SWOG Study S0003. J
Clin Oncol. 26:4771–4776. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hartung F and Weber GF: RNA blood levels
of osteopontin splice variants are cancer markers. Springerplus.
2:1102013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dubreuil G, Magliano M, Dubrana MP, Lozano
J, Lecomte P, Favery B, Abad P and Rosso MN: Tobacco rattle virus
mediates gene silencing in a plant parasitic root-knot nematode. J
Exp Bot. 60:4041–4050. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stein P, Svoboda P and Schultz RM:
RNAi-based methods for gene silencing in mouse oocytes. Methods Mol
Biol. 957:135–151. 2013. View Article : Google Scholar
|
|
18
|
Meister G and Tuschl T: Mechanisms of gene
silencing by double-stranded RNA. Nature. 431:343–349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salido-Guadarrama I, Romero-Cordoba S,
Peralta-Zaragoza O, Hidalgo-Miranda A and Rodríguez-Dorantes M:
MicroRNAs transported by exosomes in body fluids as mediators of
intercellular communication in cancer. Onco Targets Ther.
7:1327–1338. 2014.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Sørensen ES, Højrup P and Petersen TE:
Posttranslational modifications of bovine osteopontin:
identification of twenty-eight phosphorylation and three
O-glycosylation sites. Protein Sci. 4:2040–2049. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mi Z, Guo H and Kuo PC: Identification of
osteopontin-dependent signaling pathways in a mouse model of human
breast cancer. BMC Res Notes. 2:1192009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shevde LA, Samant RS, Paik JC, Metge BJ,
Chambers AF, Casey G, Frost AR and Welch DR: Osteopontin knockdown
suppresses tumorigenicity of human metastatic breast carcinoma,
MDA-MB-435. Clin Exp Metastasis. 23:123–133. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao C, Mi Z, Guo H and Kuo PC: Osteopontin
regulates ubiquitin-dependent degradation of Stat1 in murine
mammary epithelial tumor cells. Neoplasia. 9:699–706. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wai PY, Mi Z, Guo H, Sarraf-Yazdi S, Gao
C, Wei J, Marroquin CE, Clary B and Kuo PC: Osteopontin silencing
by small interfering RNA suppresses in vitro and in vivo CT26
murine colon adenocarcinoma metastasis. Carcinogenesis. 26:741–751.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zaravinos A, Lambrou GI, Volanis D,
Delakas D and Spandidos DA: Spotlight on differentially expressed
genes in urinary bladder cancer. PLoS One. 6:e182552011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rangaswami H, Bulbule A and Kundu GC:
Osteopontin: role in cell signaling and cancer progression. Trends
Cell Biol. 16:79–87. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Castellano G, Malaponte G, Mazzarino MC,
Figini M, Marchese F, Gangemi P, Travali S, Stivala F, Canevari S
and Libra M: Activation of the osteopontin/matrix
metalloproteinase-9 pathway correlates with prostate cancer
progression. Clin Cancer Res. 14:7470–7480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Likui W, Hong W, Shuwen Z, Yuangang Y and
Yan W: The potential of osteopontin as a therapeutic target for
human colorectal cancer. J Gastrointest Surg. 15:652–659. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anborgh PH, Mutrie JC, Tuck AB and
Chambers AF: Pre- and post-translational regulation of osteopontin
in cancer. J Cell Commun Signal. 5:111–122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramchandani D and Weber GF: An osteopontin
promoter polymorphism is associated with aggressiveness in breast
cancer. Oncol Rep. 30:1860–1868. 2013.PubMed/NCBI
|
|
32
|
Rangaswami H, Bulbule A and Kundu GC:
Nuclear factor-inducing kinase plays a crucial role in
osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear
factor kappaB-mediated promatrix metalloproteinase-9 activation. J
Biol Chem. 279:38921–38935. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang X, Li J, Yu B, Su L, Yu Y, Yan M, Liu
B and Zhu Z: Osteopontin splice variants differentially exert
clinicopathological features and biological functions in gastric
cancer. Int J Biol Sci. 9:55–66. 2013. View Article : Google Scholar : PubMed/NCBI
|
